Try our Advanced Search for more refined results

APOTEX, INC. v. CEPHALON, INC. et al

  1. June 23, 2014

    Provigil Judge Nixes Conspiracy Claims In Antitrust Suit

    A Pennsylvania federal judge ruled on Monday that Apotex Inc. and Provigil buyers could not prove that reverse payment patent settlements Cephalon Inc. inked with four generic-drug makers amounted to a conspiracy among the defendants to keep cheaper versions of the narcolepsy drug off the market.

  2. March 28, 2014

    Apotex Says It Doesn't Need To Re-Prove Cephalon Deceit

    Apotex Inc. urged a Pennsylvania federal judge on Thursday to rethink an order requiring it to relitigate, in an upcoming antitrust trial, the issue of whether Cephalon Inc. intended to deceive officials about the validity of its Provigil patent.

  3. August 30, 2012

    FTC Cephalon Case Stayed Pending K-Dur Supreme Court Bid

    A judge overseeing a long-running pay-for-delay dispute brought by the Federal Trade Commission and others against Cephalon Inc. stayed the cases Wednesday over the objections of the plaintiffs until the U.S. Supreme Court decides whether to hear another case on the underlying antitrust issue.

  4. March 30, 2012

    Judge Says Apotex Generic Doesn't Infringe Cephalon Patent

    A Pennsylvania federal judge on Wednesday said an abbreviated new drug application by Apotex, Inc. does not infringe Cephalon Inc.'s patent for its narcolepsy drug Provigil, finding Apotex's method for producing its proposed generic differs from Cephalon's process.

  5. October 31, 2011

    Cephalon Patent Found Invalid In Pay-For-Delay Case

    The Pennsylvania federal judge overseeing consolidated suits accusing Cephalon Inc. of conspiring to keep generic versions of its narcolepsy drug Provigil off the market ruled Monday that Apotex Inc. had proven Cephalon's patent for the drug was invalid and unenforceable.

  6. March 17, 2011

    Apotex Doesn't Infringe Provigil Patent, Judge Says

    The Pennsylvania federal judge overseeing consolidated suits accusing Cephalon Inc. of conspiring to keep generic versions of narcolepsy drug Provigil off the market ruled Tuesday that Apotex Inc.'s proposed generic does not infringe a Cephalon patent.

  7. March 04, 2011

    Cephalon Bid For Apotex Docs Denied In Provigil Suit

    A Pennsylvania federal judge ruled Friday that Cephalon Inc. was not entitled to data on Apotex Inc.'s manufacturing practices in an antitrust suit accusing Cephalon of conspiring to keep generic versions of its narcolepsy drug Provigil off the market.

  8. June 30, 2006

    Cephalon Takes Another Blow Over Provigil

    As the battle over Cephalon Inc.’s narcolepsy drug Provigil continues to swell, generic drug maker Apotex has joined the fray, filing its own lawsuit accusing the pharmaceutical company and a slew of rival generic makers of barring competition by entering into a deal to delay introducing copycat versions of the drug.